“The RE-UNITE-PN Study Design – A Prospective, Non-Interventional, Phase 4 Study of Nemolizumab for the Treatment of Prurigo Nodularis”. SKIN The Journal of Cutaneous Medicine 10, no. 2 (March 10, 2026): s767. Accessed May 1, 2026. https://skin.dermsquared.com/skin/article/view/4122.